Hear more from our interview with Dr. Childs, where he talks about his inventive career in medicine and the best and worst parts of his day.
Recent Articles
NIH-Sponsored COVID-19 Vaccine Trials Launch with 30,000 Volunteers
Phase III clinical trials to evaluate mRNA-1273, an investigational vaccine against COVID-19 developed by the National Institutes of Health (NIH) and drug developer Moderna,...
President Trump Introduces Executive Orders Addressing Drug Prices
President Donald Trump has announced four new executive orders that are aimed at lowering drug prices. The orders instruct the Department of Health and...
FDA Grants Accelerated Approval to First CAR-T Treatment for Mantle Cell Lymphoma
The FDA granted accelerated approval to brexucabtagene autoleucel (formerly KTE-X19), a chimeric antigen receptor (CAR) T-cell therapy for the treatment of adult patients with...
Report Finds Medicare Could Run Out of Funds as Early as 2022
A report from Medicare’s trustees in April 2020 estimated that the program’s Part A trust fund, which subsidizes hospital and other inpatient care, would...
Isatuximab Plus Carfilzomib: A New Standard for Relapsed/Refractory Myeloma?
The three-drug combination of the CD38-targeting antibody isatuximab plus carfilzomib and dexamethasone significantly improved progression-free survival (PFS) in patients with relapsed or refractory multiple...
Current Issue
August 2020 Volume 6, Issue 10
This issue looks at the rapid expansion of telemedicine, explores access to leukemia treatment in Brazil, and more.
